Status
Operational
Law Signed:
2013
QUALIFYING CONDITIONS
- ALS
- Alzheimer’s disease
- Autism
- Cachexia
- Cancer
- Chemotherapy induced anorexia
- Chronic Pain
- Chronic pancreatitis
- Crohn’s disease
- Ehlers-Danlos syndrome
- Elevated intraocular pressure
- Epilepsy
- Generalized anxiety disorder
- Glaucoma
- Hepatitis C (currently receiving antiviral treatment)
- HIV/AIDS
- Insomnia
- Lupus
- Moderate to severe vomiting
- Multiple Sclerosis
- Muscular Dystrophy
- Nausea
- Opioid use disorder
- Parkinson’s disease
- Persistent muscle spasms
- Post-Traumatic Stress Disorder
- Seizures
- Severe pain
- Spinal cord injury or disease
- Traumatic brain injury
- Wasting syndrome
- ** In addition to these explicitly stated conditions, healthcare providers may also issue a medical cannabis recommendation in any instance where they believe that “the potential benefits of using therapeutic cannabis would, in the provider’s clinical opinion, likely outweigh the potential health risks for the patient.”
PATIENT POSSESSION LIMITS
Two ounces
HOME CULTIVATION
No
STATE-LICENSED DISPENSARIES
Yes. Initially the total number of licensed dispensaries was capped at no more than four. Legislation signed into law in 2018 lifts this cap for specific counties.
STATE-LICENSED DISPENSARIES OPERATIONAL
Yes
DELIVERY
- Yes
CAREGIVERS
No
ESTIMATED NUMBER OF REGISTERED PATIENTS
- 13,634
- Source: Therapeutic Cannabis Program, as of June 2023
EMPLOYMENT PROTECTIONS FOR QUALIFYING PATIENTS
- No
RECIPROCITY
Yes. Effective October 1, 2024, HB 1278 removes restrictions on visiting out-of-state patients who access a NH-licensed Alternative Treatment Center (ATC) more than 3 times per year. Visitors from out of state and from Canada, who have documentation that they are allowed to possess cannabis for therapeutic purposes in their state or province, may now purchase therapeutic cannabis from a NH ATC at the same frequency as NH qualifying patients, regardless of their qualifying medical condition.